https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32527 Wed 17 Nov 2021 16:31:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36606 Wed 17 Nov 2021 16:31:32 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47156 Public Health Consequences of E-Cigarettes from the United States NASEM was accepted as reflective of evidence to mid-2017. A search for papers subsequently published in peer-reviewed journals was conducted in August 2018. A small number of robust and important papers published until March 2019 were also identified and included. Groups identified studies that extended, modified or contradicted the NASEM report. A total of 3793 papers were identified and reviewed, with summaries and draft position statements developed and presented to TSANZ membership in April 2019. After feedback from members and external reviewers, a collection of position statements was finalized in December 2019. EC have adverse lung effects and harmful effects of long-term use are unknown. EC are unsuitable consumer products for recreational use, part-substitution for smoking or long-term exclusive use by former smokers. Smokers who require support to quit smoking should be directed towards approved medication in conjunction with behavioural support as having the strongest evidence for efficacy and safety. No specific EC product can be recommended as effective and safe for smoking cessation. Smoking cessation claims in relation to EC should be assessed by established regulators.]]> Wed 14 Dec 2022 15:34:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18585 Wed 11 Apr 2018 15:35:46 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51997 Tue 26 Sep 2023 11:07:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18137 Sat 24 Mar 2018 08:04:44 AEDT ]]>